STO is governed by a Board of Directors. The Co-Chairmen of the Board of Directors are Richard M. Goldberg, MD, from the University of North Carolina and Patrick G. Johnston, MD. PhD, from Queens University, Belfast.  They provide guidance to the staff and committees of the Society.

The CME Program is overseen by the CME CO-Chairs whose function it is to provide subspecialized expertise on specific cancer types:

CME Co-Editors:

Frank M. Balis, MD
Director of Oncology Clinical Research,
The Children's Hospital of Philadelphia

Michael Joel Haut, MD
Clinical Professor of Medicine                 
Pennsylvania Hospital
University of Pennsylvania

CME Associate Editor:

Jayne S. Gurtler, MD
East Jefferson Hospital
Metairie, Louisiana

CME Statistical Editor:

Charles R. Sherman, PhD
Retired Deputy Director of the Office of Medical Applications of Research of the National Institutes of Health

In addition, the clinical content of CME activities and Journal articles is managed by the Medical Advisory Committee (MAC). Members of the MAC represent some of the leading authorities in oncology worldwide. The MAC develops and implements policies concerning the scientific accuracy and fair balance of all CME activities. In addition, they oversee the resolution of conflicts of interest, and assure that activities are free of commercial bias.

Medical Advisors:
Bruce A. Chabner, MD
Eli Glatstein, MD
Gabriel N. Hortobagyi, MD
Patrick G. Johnston, MD., PhD
John E. Niederhuber, MD
H.M. Pinedo, MD., PhD